Endexx Corporation’s (OTC: EDXC) Blesswell™ Men’s Premium Skincare Line Expands To 13 Countries Through Amazon (NASDAQ: AMZN); Todd Da-vis, EDXC CEO, Says Sales International Channel Expansion ‘Will Help To En-sure Our Future Growth’

 In NASDAQ: AMZN, NASDAQ: CGC, NASDAQ: OGI, NASDAQ: WBA, NYSE: ACB, NYSE: CVS, NYSE: TGT, OTC PINK: EDXC, OTC: EDCX, OTC: SPRWF, OTCQX: TGODF, TSX: ACB, TSX: TGOD

Endexx Corporation’s (OTC: EDXC) Blesswell™ men’s premium skincare line expands to 13 countries through Amazon (NASDAQ: AMZN). Todd Davis, EDXC CEO, says sales international channel expansion, “Will help to ensure our future growth’.  He adds that EDXC’s recent acquisition of non-nicotine plant based Guarana-based vaping brand HYLA allows for ‘significant international access’ for all Endexx product lines.

StockMarketPress is  a media company which is spotlighting the cannabis industry analyzing how growth in cannabis legalization by state in 2022 could impact companies and investors. Some of the stocks it recently reported on include Endexx Corporation (OTC: EDXC), Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS) Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF), The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), OrganiGram Holdings Inc. (NASDAQ: OGI), Canopy Growth Corp. (NASDAQ: CGC) CBD Unlimited, Inc. (OTC PINK: EDXC).

The Company reported that in addition to the online distribution it has in the United States, the Blesswell™ men’s premium skincare line is also available now through Amazon (NASDAQ: AMZN) in Australia, Belgium, Canada, France, Germany, Italy, Japan, Mexico, Netherlands, Poland, Spain, Sweden and the United Kingdom.

Todd Davis, CEO and Chairman of Endexx®, says, “ The expansion into international distribution for our Blesswell™ brand through Amazon is supportive of our overall distribution strategy across all of our product lines. Having recently acquired HYLA, a non-nicotine, guarana-based vape line with significant international distribution, we are now poised to offer all of our products throughout the world, whether through key retailers like CVS, Target and Walgreens, both nationally and internationally via Amazon for our Blesswell™ men’s skin care line or through a large network of international distributors, which was a key component and part of our attraction to the HYLA acquisition.”

Davis added, “We believe these channels will help to ensure our future  growth and we look forward continuing to update investors on the progress we make on each of our product lines.”

Endexx recently announced its launch of products on Amazon (NASDAQ: AMZN) and Target (NYSE: TGT). It also placed and markets its various health and skincare products at four of the top eight retailers in the United States, including Blesswell™ and other brands, at Walgreens (NASDAQ: WBA) and CVS stores (NYSE: CVS).

The Exdexx Blesswell™ product line combines the premium quality of high end ingredients with a price sensitivity that allows it to be easily accessible across multiple market segments. It is recently available on Amazon (NASDAQ: AMZN). The line was created to introduce men to a whole body, holistic form of self-care which was inspired by men increasing their pursuit for wellness and the natural environment, the Company says. The brand is committed to a holistic approach  and delivers on its promise to keep products paraben and sulfate-free, vegan, and absent of any ingredient that utilizes animal testing.

Earlier, Endexx Corporation (OTC: EDXC) recently announced its controlling-interest subsidiary plant-based vape 4,500 system Hyla secured two purchase orders for greater than 200,000 units combined within the first month of its acquisition.

Combined, these orders are for 150,000 units and 52,000 units. They occurred within the first month of the acquisition by EDXC of the Hyla vaping brand.

Hyla develops and distributes zero-nicotine plant-powered, vape-delivered made with vegan formulations and functional plant extract ingredients. It utilizes Guarana and Levodopa plant extract ingredients.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com https://twitter.com/PressStock

Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press